In our series, three of 21 patients with EMPD had PD-L1+ tumor cells, and the associated immune infiltrate consisted of varying densities of CD3+, CD8+, PD-1+, and PD-L1+ cells. The gene discussed is CD8A; the disease is neoplasm.